Megan Lerner to Glioma
This is a "connection" page, showing publications Megan Lerner has written about Glioma.
Connection Strength
0.801
-
OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma. J Transl Med. 2020 11 10; 18(1):424.
Score: 0.161
-
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models. Neuro Oncol. 2017 02 01; 19(2):175-185.
Score: 0.124
-
OKN-007 decreases free radical levels in a preclinical F98 rat glioma model. Free Radic Biol Med. 2015 Oct; 87:157-68.
Score: 0.111
-
In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed. 2012 Apr; 25(4):685-94.
Score: 0.085
-
Effects of PBN and OKN007 in rodent glioma models assessed by 1H MR spectroscopy. Free Radic Biol Med. 2011 Jul 15; 51(2):490-502.
Score: 0.083
-
Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas. J Cell Mol Med. 2011 Apr; 15(4):837-49.
Score: 0.082
-
Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography. J Magn Reson Imaging. 2010 Aug; 32(2):267-75.
Score: 0.079
-
Multiparametric assessment of the anti-glioma properties of OKN007 by magnetic resonance imaging. J Magn Reson Imaging. 2010 Apr; 31(4):796-806.
Score: 0.077